Medicare AdvantagePrior AuthMedium impact
Amzeeq® (minocycline) Topical Foam (New)
Humana·Dermatology, Family Medicine, Pediatrics·Medicare Advantage
Effective date
Jul 23, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage is implementing a new prior authorization policy for Amzeeq® (minocycline) topical foam effective July 23, 2025. Coverage requires patients to have failed or be unable to tolerate both topical retinoids and oral antibiotics before approval for this acne treatment.
Action Required
By July 23, 2025: Billing and clinical teams must implement prior authorization requirements for Amzeeq® (minocycline) topical foam prescriptions for Medicare Advantage patients. Ensure documentation shows patient has tried/failed topical retinoids (tretinoin, adapalene) and oral antibiotics (minocycline, doxycycline) before prescribing. Update EMR templates to capture required prior treatment history. Claims without prior authorization will be denied.